Pluri Inc. (TLV:PLUR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,762.00
+25.00 (1.44%)
May 7, 2025, 4:48 PM IDT
-18.46%
Market Cap 135.67M
Revenue (ttm) 2.47M
Net Income (ttm) -72.34M
Shares Out n/a
EPS (ttm) -13.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,835
Average Volume 15,043
Open 1,760.00
Previous Close 1,737.00
Day's Range 1,670.00 - 1,779.00
52-Week Range 1,299.00 - 2,350.00
Beta n/a
RSI 54.35
Earnings Date May 9, 2025

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acut... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 118
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PLUR
Full Company Profile

Financial Performance

In 2024, Pluri's revenue was $326,000, an increase of 13.59% compared to the previous year's $287,000. Losses were -$20.89 million, -26.25% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.